[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355631-105":59,"doc-detail-355631-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","contrasting-features-of-papillary-and-chromophobe-renal-cell-carcinoma-revealed-by-whole-genome-sequencing","Contrasting Features of Papillary and Chromophobe Renal Cell Carcinoma Revealed by Whole-Genome Sequencing","","Whole-genome sequencing was used to analyze 164 tumor–normal pairs from the Genomics England 100,000 Genomes Project to map copy number alterations, structural variation, and key genomic features in renal cell carcinoma subtypes. The work contrasts papillary RCC (pRCC) and chromophobe RCC (ChRCC) against the previously dominant clear cell focus. Findings link specific genomic alterations to histologic diversification and suggest immune-escape mechanisms contributing to subtype development. The study highlights distinct genetics with implications for patient treatment and clinical trial design.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/contrasting-features-of-papillary-and-chromophobe-renal-cell-carcinoma-revealed-by-whole-genome-sequencing/355631/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/contrasting-features-of-papillary-and-chromophobe-renal-cell-carcinoma-revealed-by-whole-genome-sequencing/355631.png","ImageObject",300,407,{"name":92,"@type":93},"นรินทร์","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What data and cohort were used for the study?","Question",{"text":112,"@type":113},"The analysis used whole-genome sequencing data from 164 tumor–normal pairs recruited through the Genomics England 100,000 Genomes Project.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the study address differences between RCC subtypes?",{"text":117,"@type":113},"It focuses on less common papillary RCC (pRCC) and chromophobe RCC (ChRCC), which have had limited sequencing analyses compared with clear cell RCC.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the main outcome and implication of the results?",{"text":121,"@type":113},"The study correlates genomic alterations with histologic diversification and discusses how genetically mediated immune escape may contribute to these subtypes, informing treatment and clinical trials.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355631,1790563179,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","Contrasting Features of Papillary and Chromophobe Renal Cell Carcinoma Revealed by Whole-Genome Sequencing  \nRichard Culliford1, Charlie Mills1, Daniel Chubb1, Ben Kinnersley1,2, Amit Sud1, Alex J. Cornish1, Lisa Browning3, Samuel E. D. Lawrence1, Robert Bentham2, Anna Frangou4,5, Andreas J. Gruber6, Kevin Litchfield7, David C. Wedge8,9, James Larkin10,11, Samra Turajlic10,11,12, and Richard S. Houlston1  \n|  |  | A |  | B | S |  | T | R |  | A |  | C | T |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n|  | The identification of cancer drivers is a cornerstone to the delivery of precision oncology. So far, sequencing of renal cell cancer (RCC) has largely been confined to the clear cell subtype of RCC. In contrast, sequencing analyses of the less common forms of RCC, papillary RCC (pRCC) and chromophobe RCC (ChRCC), have so far been limited. We analyzed whole-genome sequencing data on 164 tumor–normal pairs from the Genomics England 100,000 Genomes Project, providing a comprehensive, high-resolution map of copy number alterations, structural variation, and key global genomic\u003Cbr>􀀶 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | features, including mutational signatures, intratumor heterogeneity, and analysis of extrachromosomal DNA formation. Our research establishes correlations between genomic alterations and histologic diversification and the extent to which genetically-mediated immune escape contributes to the development of these RCC subtypes.\u003Cbr>Implications: We demonstrate the distinctive genetics that characterizes pRCC and ChRCC and how this information has the potential to inform patient treatment and clinical trials. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n\nIntroduction  \nMost kidney cancers are renal cell carcinomas (RCC) . The World Health Organization (WHO; fifth edition) classification of RCC recognizes more than 20 subtypes (1), with 70% to 90% having clear cell histology (ccRCC) . There has been significant progress in the treatment of ccRCC over the past 20 years (2) . In contrast, less progress has been made in the treatment of papillary RCC (pRCC) and chromophobe RCC (ChRCC), which account for 13% to 20% and 5% to 7% of RCC cases, respectively (3) .  \n1Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom. 2Department of Oncology, University College London Cancer Institute, London, United Kingdom. 3Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom. 4Algebraic Systems Biology, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany. 5Algebraic Systems Biology, Centre for Systems Biology Dresden, Dresden, Germany. 6Department of Biology, University of Konstanz, Konstanz, Germany. 7The Tumour Immunogenomics and Immunosurveillance Lab, University College London Cancer Institute, London, United Kingdom. 8Manchester Cancer Research Centre, University of Manchester, Manchester, UK. 9NIHR Manches","cbCainhb6ZrqaYgB","https://ap.wps.com/l/cbCainhb6ZrqaYgB","pdf",3299160,"English","# Introduction\n# Materials and Methods\n## Patients and ethics","[{\"question\":\"What data and cohort were used for the study?\",\"answer\":\"The analysis used whole-genome sequencing data from 164 tumor–normal pairs recruited through the Genomics England 100,000 Genomes Project.\"},{\"question\":\"How does the study address differences between RCC subtypes?\",\"answer\":\"It focuses on less common papillary RCC (pRCC) and chromophobe RCC (ChRCC), which have had limited sequencing analyses compared with clear cell RCC.\"},{\"question\":\"What is the main outcome and implication of the results?\",\"answer\":\"The study correlates genomic alterations with histologic diversification and discusses how genetically mediated immune escape may contribute to these subtypes, informing treatment and clinical trials.\"}]","Contrasting Features of Papillary and Chromophobe Renal Cell Carcinoma Revealed by Whole-Genome Sequencing | PDF",1790120219,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/644416ebdc69dd2cc77494a866521c75.webp",983,1315,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a8a66c6727fabcc7e1d4d90afe55f71.webp",982,1314,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e764cf3044597d0d2601493c4e9d90f0.webp",981,1312,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92c9690826f9e9570d779f508dd51a8c.webp",980,1311]